Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.39 |
| ▸ | GABRE | P78334 | 1/20 | 0.39 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.39 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.39 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.39 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15785701 | 0.82 | GABRP (0.41) | KDM4ELMNACYP2C19GABRPGABRD | |
| SCHEMBL5858279 | 0.81 | GABRP (0.37) | KDM4ELMNACYP2C19GABRPGABRD | |
| SCHEMBL10035704 | 0.78 | GABRP (0.38) | KDM4ELMNACYP2C19GABRPGABRD | |
| SCHEMBL5856557 | 0.77 | TSHR (0.36) | KDM4ELMNACYP2C19TSHRNPSR1 | |
| SCHEMBL7736395 | 0.76 | — | — | |
| SCHEMBL18268912 | 0.76 | — | — | |
| SCHEMBL18268905 | 0.73 | LMNA (0.53) | KDM4ELMNACYP2C19GABRPGABRD | |
| SCHEMBL14904471 | 0.73 | GABRP (0.35) | KDM4ELMNACYP2C19GABRPGABRD | |
| SCHEMBL10766747 | 0.73 | LMNA (0.53) | KDM4ELMNACYP2C19GABRPGABRD | |
| SCHEMBL159517 | 0.73 | ALDH1A1 (0.44) | KDM4ELMNATSHRNPSR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120157861-A | Polyester resin for low-temperature curing powder coating, preparation method of polyester resin and low-temperature curing powder coating | 黄山嘉恒科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-119798627-A | Method for preparing hydroxyl-terminated high molecular polyester polyol without metal catalyst and polyester polyol | 北京高盟新材料股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118852022-B | Gemini quaternary ammonium salt antibacterial agent, preparation thereof and application thereof in antibacterial polyester synthesis | 浙江大学 | 2025-03-28 | — | — | CN | claimed |
| CN-118852022-A | Gemini quaternary ammonium salt antibacterial agent, preparation thereof and application thereof in antibacterial polyester synthesis | 浙江大学 | 2024-10-29 | — | — | CN | claimed |
| CN-114591501-B | Composite catalyst, carbon dioxide-based copolymer, and preparation method and application thereof | 华峰集团有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-118480174-A | Aliphatic polycarbonate, preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-08-13 | — | — | CN | claimed |
| US-11912818-B2 | Method for synthesizing aromatic-aliphatic copolyester without catalyst and product thereof | ZHEJIANG UNIVERSITY (CN) | 2024-02-27 | — | — | US | claimed |
| US-20230391948-A1 | METHOD FOR SYNTHESIZING AROMATIC-ALIPHATIC COPOLYESTER WITHOUT CATALYST AND PRODUCT THEREOF | ZHEJIANG UNIVERSITY (CN) | 2023-12-07 | — | — | US | claimed |
| CN-114644758-B | Anti-mud water reducer and preparation method thereof | 南京博特新材料有限公司 | 2023-03-14 | — | — | CN | claimed |
| WO-2022148259-A1 | METHOD FOR SYNTHESIZING AROMATIC-ALIPHATIC COPOLYESTER WITHOUT CATALYST, AND PRODUCT THEREOF | 浙江大学 | 2022-07-14 | — | — | WO | claimed |
| US-20040215038-A1 | Colorant precursor compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215002-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215022-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040214918-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-6790267-B1 | METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION | 2004-09-14 | — | — | US | claimed |
| US-6764541-B1 | Colorant compositions | XEROX CORPORATION | 2004-07-20 | — | — | US | claimed |
| US-6583248-B1 | Methacrylate groups; dental cement | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION | 2003-06-24 | — | — | US | claimed |
| US-6180739-B1 | CYCLODEXTRINS WITH ACRYLATE AND ANHYDRIDES | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION | 2001-01-30 | — | — | US | claimed |
| US-5929131-A | Polymerizable cyclodextrin derivatives | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1999-07-27 | — | — | US | claimed |
| US-5792821-A | Polymerizable cyclodextrin derivatives | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1998-08-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040215022-A1 | Colorant compositions | ARSA, TST, IK | KDM4E 1729/4885LMNA 2953/4885CYP2C19 2370/4885 |
| US-20040215038-A1 | Colorant precursor compositions | RB1, SULT1A1, CBR1 | KDM4E 2026/4885LMNA 599/4885CYP2C19 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.